ANIPNasdaq United States
Market cap
$1.757 B
$78.25 -5.30%
Close of 7 Aug 2026
Revenue
$883.4M
#1594 by revenue
Earnings
$78.0M
#1405 by earnings
Shares outstanding
22,491,281
Latest filing cover page
P/E ratio
22.5
Cap ÷ net income
Where these numbers come from
Share counts and financials for Ani Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.